NDC 80491-7825

QUVIVIQ

Daridorexant

QUVIVIQ is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Idorsia Pharmaceuticals Ltd. The primary component is Daridorexant.

• Product ID: 80491-7825_3784b72d-63d2-47f9-9df6-4123e142911f
• NDC: 80491-7825
• Product Type: Human Prescription Drug
• Proprietary Name: QUVIVIQ
• Generic Name: Daridorexant
• Dosage Form: Tablet, Film Coated
• Route of Administration: ORAL
• Marketing Start Date: 2022-04-07
• Marketing Category: NDA /
• Application Number: NDA214985
• Labeler Name: Idorsia Pharmaceuticals Ltd
• Substance Name: DARIDOREXANT
• Active Ingredient Strength: 25 mg/1
• Pharm Classes: Orexin Receptor Antagonist [EPC], Orexin Receptor Antagonists [MoA]
• DEA Schedule: CIV
• NDC Exclude Flag: N
• Listing Certified Through: 2023-12-31

Packaging

NDC 80491-7825-3

1 BOTTLE in 1 CARTON (80491-7825-3) > 30 TABLET, FILM COATED in 1 BOTTLE

• Marketing Start Date: 2022-04-07
• NDC Exclude Flag: N
• Sample Package?: N

Drug Details

NDC Crossover Matching brand name "QUVIVIQ" or generic name "Daridorexant"

NDC	Brand Name	Generic Name
80491-7825	QUVIVIQ	Daridorexant
80491-7850	QUVIVIQ	Daridorexant